Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 4, 1992 - Issue 3
58
Views
40
CrossRef citations to date
0
Altmetric
Research Article

Relative Mesothelioma Induction in Rats by Mineral Fibers: Comparison with Residual Pulmonary Mineral Fiber Number and Epidemiology

, &
Pages 273-300 | Published online: 27 Sep 2008
 

Abstract

Large differences in mesothelioma induction by various minerals were demonstrated in rats on the basis of tumor to fiber ratios. Erinoite was 500–800 times more tumorigenic and crocidolite 30–60 times more tumorigenic than chysotile. Erionite was relatively more potent when introduced intratrachealy than either asbestos. These data rank similarly to human exposure to the same mineral fibers. We propose that a factor here termed intrinsic potency probably related to surface activity overrides both fiber number and geometric configuration when fibers of strongly different tumorigenicity are compared. This potency difference may be related to differing tendencies of the respective surfaces to coordinate endogenous iron and release free radicals via the fenton reaction during the reduction from the ferric to the ferrous state. It is suggested that such potency differences may explain the failure of certain man-made fibers to induce mesothelioma from inhalation exposure because of insufficient dose reaching the mesothelium.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.